vs
GYRE THERAPEUTICS, INC.（GYRE）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
GYRE THERAPEUTICS, INC.的季度营收约是REDWOOD TRUST INC的1.4倍（$37.2M vs $25.9M），REDWOOD TRUST INC净利率更高（77.2% vs -3.7%，领先80.9%），GYRE THERAPEUTICS, INC.同比增速更快（33.4% vs -6.1%），过去两年GYRE THERAPEUTICS, INC.的营收复合增速更高（17.0% vs -41.0%）
GYRE Therapeutics是一家临床阶段生物制药企业，专注于开发针对难治性血液系统恶性肿瘤和实体瘤的新型靶向疗法，聚焦精准肿瘤学领域以满足未被满足的患者医疗需求，主要在北美地区开展业务。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
GYRE vs RWT — 直观对比
营收规模更大
GYRE
是对方的1.4倍
$25.9M
营收增速更快
GYRE
高出39.5%
-6.1%
净利率更高
RWT
高出80.9%
-3.7%
两年增速更快
GYRE
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.2M | $25.9M |
| 净利润 | $-1.4M | $20.0M |
| 毛利率 | 95.3% | — |
| 营业利润率 | 0.3% | — |
| 净利率 | -3.7% | 77.2% |
| 营收同比 | 33.4% | -6.1% |
| 净利润同比 | -340.1% | 402.6% |
| 每股收益（稀释后） | $-0.01 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GYRERWT
| Q4 25 | $37.2M | $25.9M | ||
| Q3 25 | $30.6M | $15.0M | ||
| Q2 25 | $26.8M | $13.8M | ||
| Q1 25 | $22.1M | $27.9M | ||
| Q4 24 | $27.9M | $27.6M | ||
| Q3 24 | $25.5M | $25.5M | ||
| Q2 24 | $25.2M | $67.4M | ||
| Q1 24 | $27.2M | $74.5M |
净利润GYRERWT
| Q4 25 | $-1.4M | $20.0M | ||
| Q3 25 | $5.9M | $-7.7M | ||
| Q2 25 | $1.6M | $-98.5M | ||
| Q1 25 | $3.7M | $16.1M | ||
| Q4 24 | $569.0K | $-6.6M | ||
| Q3 24 | $2.9M | $14.8M | ||
| Q2 24 | $4.5M | $15.5M | ||
| Q1 24 | $9.9M | $30.3M |
毛利率GYRERWT
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
营业利润率GYRERWT
| Q4 25 | 0.3% | — | ||
| Q3 25 | 22.7% | -9.0% | ||
| Q2 25 | 8.1% | -679.0% | ||
| Q1 25 | 10.3% | 80.2% | ||
| Q4 24 | 2.4% | -1.3% | ||
| Q3 24 | 16.6% | 86.1% | ||
| Q2 24 | 12.7% | 30.3% | ||
| Q1 24 | 29.7% | 41.3% |
净利率GYRERWT
| Q4 25 | -3.7% | 77.2% | ||
| Q3 25 | 19.4% | -51.4% | ||
| Q2 25 | 5.9% | -712.0% | ||
| Q1 25 | 16.9% | 57.8% | ||
| Q4 24 | 2.0% | -24.0% | ||
| Q3 24 | 11.2% | 58.1% | ||
| Q2 24 | 18.0% | 23.0% | ||
| Q1 24 | 36.6% | 40.6% |
每股收益（稀释后）GYRERWT
| Q4 25 | $-0.01 | $0.11 | ||
| Q3 25 | $0.03 | $-0.08 | ||
| Q2 25 | $0.00 | $-0.76 | ||
| Q1 25 | $0.00 | $0.10 | ||
| Q4 24 | $0.00 | $-0.08 | ||
| Q3 24 | $0.01 | $0.09 | ||
| Q2 24 | $0.01 | $0.10 | ||
| Q1 24 | $0.03 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.4M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $106.0M | $982.6M |
| 总资产 | $166.1M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GYRERWT
| Q4 25 | $52.4M | $255.7M | ||
| Q3 25 | $60.0M | $226.3M | ||
| Q2 25 | $54.4M | $302.0M | ||
| Q1 25 | $29.9M | $259.9M | ||
| Q4 24 | $26.7M | $245.2M | ||
| Q3 24 | $25.1M | $253.7M | ||
| Q2 24 | $25.1M | $275.6M | ||
| Q1 24 | $37.4M | $275.4M |
总债务GYRERWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.7B |
股东权益GYRERWT
| Q4 25 | $106.0M | $982.6M | ||
| Q3 25 | $101.9M | $999.0M | ||
| Q2 25 | $92.0M | $1.1B | ||
| Q1 25 | $68.1M | $1.2B | ||
| Q4 24 | $63.3M | $1.2B | ||
| Q3 24 | $63.2M | $1.2B | ||
| Q2 24 | $60.4M | $1.2B | ||
| Q1 24 | $56.6M | $1.2B |
总资产GYRERWT
| Q4 25 | $166.1M | $23.7B | ||
| Q3 25 | $159.4M | $22.6B | ||
| Q2 25 | $152.6M | $21.3B | ||
| Q1 25 | $129.8M | $19.9B | ||
| Q4 24 | $125.4M | $18.3B | ||
| Q3 24 | $125.2M | $18.4B | ||
| Q2 24 | $120.9M | $16.5B | ||
| Q1 24 | $122.0M | $15.1B |
负债/权益比GYRERWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.6M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-5.8M | — |
| 自由现金流率自由现金流/营收 | -15.5% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-180.0K | — |
8季度趋势，按日历期对齐
经营现金流GYRERWT
| Q4 25 | $-5.6M | $-10.1B | ||
| Q3 25 | $4.7M | $-2.7B | ||
| Q2 25 | $2.1M | $-2.1B | ||
| Q1 25 | $-129.0K | $-2.0B | ||
| Q4 24 | $-2.8M | $-5.9B | ||
| Q3 24 | $1.7M | $-2.1B | ||
| Q2 24 | $-5.5M | $-2.0B | ||
| Q1 24 | $2.9M | $-954.2M |
自由现金流GYRERWT
| Q4 25 | $-5.8M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $-251.0K | — | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $2.7M | — |
自由现金流率GYRERWT
| Q4 25 | -15.5% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -10.1% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | -27.5% | — | ||
| Q1 24 | 9.8% | — |
资本支出强度GYRERWT
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 0.9% | — |
现金转化率GYRERWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 1.32× | — | ||
| Q1 25 | -0.03× | -120.92× | ||
| Q4 24 | -4.85× | — | ||
| Q3 24 | 0.60× | -140.86× | ||
| Q2 24 | -1.21× | -126.56× | ||
| Q1 24 | 0.29× | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
